BD - Worldwide
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.
BD focuses strategically on achieving growth in three worldwide business segments: BD Medical, BD Diagnostics and BD Biosciences.
BD in The UK
This plant manufactures a broad range of blood collection products and systems including BD Vacutainer® tubes for haematology, coagulation and special chemistries, and supplies markets both across Europe and around the world. The Plymouth facility, which employs approximately 720 associates, also manufactures BD Biosciences - Discovery Labware products which are used by medical researchers.
This facility is home to approximately 230 sales, marketing and technical support staff from the Company's three segments: BD Medical, BD Diagnostics and BD Biosciences. The Oxford office is also the European headquarters for two of the largest units (BD Diagnostics - Preanalytical Systems and BD Medical - Medical Surgical Systems). These units are supported by a team of experts from the human resources, information technology, customer service, procurement and finance departments.
This facility employs approximately 200 associates and specialises in the development and manufacture of plastic purpose-designed drug delivery systems which are supplied to the pharmaceutical industry for filling and distribution to end users worldwide.
BD in Ireland
In April 2006, BD approved a €15 million investment to develop and expand its medical devices global manufacturing center in Drogheda. The investment prepared the Drogheda facility to manufacture a high-value prefilled syringe known as the BDTM Saline XS. The expansion has been built with capacity for a second line to cater to the rapidly growing European market.
Beginning in 1969, the Dun Laoghaire facility manufactured a variety of syringes until 1996, when the site began diversifying into pen needles, an insulin injection system for the treatment of diabetes. In January 2007, the last 0.5ml syringe was manufactured. As of April 2007, the Dun Laoghaire facility has 11 operating pen needle lines.
1 Becton Drive
Franklin Lakes, NJ USA 07417
Becton, Dickinson U.K. Limited
Registered in England: 00852702
Registered Office: The Danby Building, Edmund Halley Road, Oxford Science Park, Oxford
Oxfordshire OX4 4DQ